Your browser doesn't support javascript.
loading
Healthcare resource utilization among patients receiving non-invasive testing for coronary artery disease in an outpatient setting: A cohort study reflecting daily practice trends.
Ananthasubramaniam, Karthikeyan; Kitt, Therese M; Saxena, Akansha; Feng, Qi; Nimke, David; Spalding, James R; Xu, Yanqing.
Afiliação
  • Ananthasubramaniam K; Henry Ford West Bloomfield Hospital, Heart and Vascular Institute, 6777 W Maple, West Bloomfield, MI, 48322, USA. kananth1@hfhs.org.
  • Kitt TM; Astellas Pharma Global Development, Inc, Northbrook, IL, 60062, USA.
  • Saxena A; Astellas US LLC, Northbrook, IL, USA.
  • Feng Q; Astellas US LLC, Northbrook, IL, USA.
  • Nimke D; Astellas US LLC, Northbrook, IL, USA.
  • Spalding JR; Astellas Pharma Global Development, Inc, Northbrook, IL, 60062, USA.
  • Xu Y; Astellas Pharma Global Development, Inc, Northbrook, IL, 60062, USA.
J Nucl Cardiol ; 29(4): 1776-1787, 2022 08.
Article em En | MEDLINE | ID: mdl-33660216
ABSTRACT

BACKGROUND:

Accurate, early diagnosis and the initiation of appropriate treatment is central to reducing the clinical burden of coronary artery disease (CAD); however, real-world evidence characterizing healthcare resource utilization (HCRU) associated with testing for CAD is lacking. METHODS AND

RESULTS:

Using a non-interventional, retrospective, secondary database analysis, patients aged ≥18 years who underwent outpatient non-invasive cardiac diagnostic testing were identified. The primary objective was to gain an understanding of pre- and post-assessment care pathways and the associated interventions for patients who underwent non-invasive testing for CAD in either an outpatient or emergency department setting. Overall, chest pain was the primary reason for the index visit (54.8%), followed by shortness of breath (23.7%), myocardial infarction (MI), coronary artery disease (CAD) or congestive heart failure (CHF) (3.8%), and other (46.8%); 3.0% of patients had no apparent reason for testing in the last 45 days. Single-photon emission computed tomography (SPECT) was the dominant diagnostic testing modality (40.3%). During the 90-day follow-up, 7.3% (n = 22,083) of patients were diagnosed with CAD; among these patients, 19.4% had repeat diagnostic testing, 26.0% of patients had a revascularization procedure, and 65.6% underwent cardiac catheterization. These rates varied by testing modality.

CONCLUSIONS:

In this study of a large real-world data sample, variability in the use of non-invasive tests and HCRU were evident. These results may assist efforts to optimize system-wide care/diagnostic pathways and value-based treatment decisions for patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana Idioma: En Ano de publicação: 2022 Tipo de documento: Article